These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1678606)

  • 1. NMDA receptor antagonists inhibit ethanol-produced locomotor stimulation in NMRI mice.
    Liljequist S
    Alcohol; 1991; 8(4):309-12. PubMed ID: 1678606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine.
    Löscher W; Hönack D
    J Pharmacol Exp Ther; 1991 Feb; 256(2):432-40. PubMed ID: 1671593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A competitive antagonist of NMDA receptors CGP 40116 attenuates experimental symptoms of schizophrenia evoked by MK-801.
    Zajaczkowski W; Czyrak A; Wedzony K
    Pol J Pharmacol; 2003; 55(5):703-11. PubMed ID: 14704466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional alterations in brain amino acids after administration of the N-methyl-D-aspartate receptor antagonists MK-801 and CGP 39551 in rats.
    Löscher W; Hönack D; Fassbender CP
    Neurosci Lett; 1991 Mar; 124(1):115-8. PubMed ID: 1677457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic differences in the effects of competitive and non-competitive NMDA receptor antagonists on locomotor activity in mice.
    Liljequist S
    Psychopharmacology (Berl); 1991; 104(1):17-21. PubMed ID: 1831907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of ethanol with nicotine, dizocilpine, CGP 40116, and 1-(m-chlorophenyl)-biguanide in rats.
    Bienkowski P; Koros E; Piasecki J; Kostowski W
    Pharmacol Biochem Behav; 1997 Dec; 58(4):1159-65. PubMed ID: 9408228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of NMDA and AMPA antagonists on the locomotor activity induced by selective D1 and D2 dopamine agonists in reserpine-treated mice.
    Starr MS; Starr BS
    Psychopharmacology (Berl); 1994 Apr; 114(3):469-76. PubMed ID: 7855205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra.
    Wedzony K; Czyrak A; Maćkowiak M; Fijał K
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):517-27. PubMed ID: 8740145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats.
    Bubser M; Keseberg U; Notz PK; Schmidt WJ
    Eur J Pharmacol; 1992 Dec; 229(1):75-82. PubMed ID: 1361915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central effects of SL 82.0715, an antagonist of polyamine site of the NMDA receptor complex.
    Dereń-Wesołek A; Maj J
    Pol J Pharmacol; 1993; 45(5-6):467-80. PubMed ID: 7912135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competitive NMDA receptor antagonist, CGP 40116, substitutes for the discriminative stimulus effects of ethanol.
    Bienkowski P; Stefanski R; Kostowski W
    Eur J Pharmacol; 1996 Oct; 314(3):277-80. PubMed ID: 8957246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of the different binding sites of the N-methyl-D-aspartate (NMDA) receptor to the expression of behavior.
    Kretschmer BD; Zadow B; Volz TL; Volz L; Schmidt WJ
    J Neural Transm Gen Sect; 1992; 87(1):23-35. PubMed ID: 1346965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The new competitive NMDA receptor antagonist CGP 40116 inhibits pilocarpine-induced limbic motor seizures and unconditioned motor behaviour in the mouse.
    Starr MS; Starr BS
    Pharmacol Biochem Behav; 1994 Jan; 47(1):127-31. PubMed ID: 7906888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of noradrenaline release in the cerebral cortex via presynaptic N-methyl-D-aspartate (NMDA) receptors and their pharmacological characterization.
    Göthert M; Fink K
    J Neural Transm Suppl; 1991; 34():121-7. PubMed ID: 1687781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic interactions between NMDA-antagonists and L-dopa on activity in MPTP-treated mice.
    Fredriksson A; Gentsch C; Archer T
    J Neural Transm Gen Sect; 1994; 97(3):197-209. PubMed ID: 7873129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMDA antagonist inhibits rapid tolerance to ethanol.
    Khanna JM; Wu PH; Weiner J; Kalant H
    Brain Res Bull; 1991 Apr; 26(4):643-5. PubMed ID: 1831064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The competitive NMDA antagonists CGP 43487 and APV potentiate dopaminergic function.
    Dall'Olio R; Rimondini R; Gandolfi O
    Psychopharmacology (Berl); 1995 Apr; 118(3):310-5. PubMed ID: 7617824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of competitive and non-competitive NMDA receptor antagonists on behavioral responses induced by 7-OH-DPAT and quinpirole in rats.
    Dall'olio R; Rimondini R; Gandolfi O
    Pharmacol Res; 1997 Sep; 36(3):203-9. PubMed ID: 9367665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral sensitization to ethanol does not result in cross-sensitization to NMDA receptor antagonists.
    Meyer PJ; Phillips TJ
    Psychopharmacology (Berl); 2007 Nov; 195(1):103-15. PubMed ID: 17653696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice.
    Irifune M; Shimizu T; Nomoto M; Fukuda T
    Pharmacol Biochem Behav; 1995; 51(2-3):291-6. PubMed ID: 7667342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.